All About MS Header Photos

The epidemiology of multiple sclerosis in Europe

The epidemiology of multiple sclerosis in Europe

Multiple sclerosis (MS) is a chronic and potentially highly disabling disorder with considerable social impact and economic consequences. It is the major cause of non-traumatic disability in young adults. The social costs associated with MS are high because of its long duration, the early loss of productivity, the need for assistance in activities of daily living and the use… read more »

Vitamin D Supplements

Taking Vitamin D Supplements Lowers Risk of Multiple Sclerosis

Relapses from Stress and Infections

OBJECTIVE:

needs assessment survey

CHERRY HILL, N.J., June 27 /PRNewswire/ –

Honored for the poster presentation,

“A Needs Assessment Survey of MS Patients and Care  Partners,”

the Multiple Sclerosis Association of America (MSAA) received the Berlex
Award for the Best Poster in Patient and Family Education in Multiple
Sclerosis, at the 20th Annual Meeting of the Consortium of Multiple
Sclerosis Centers (CMSC) in Scottsdale, Arizona, June 1st – 3rd. As the
winner of the Berlex Award, MSAA will receive free meeting 
registration… read more »

MSAA publications

All of MSAA’s publications are printed in full color, with large print, colorful text, and interesting photos. Our explanations are clearly written, using the most up-to-date research available, and all medical information is reviewed by our chief medical officer. We also strive to keep a positive voice throughout our writing. From these efforts, our booklets are comfortable to read and easy to understand, providing important information along with hope… read more »

Azathioprine – difficulties after long-term treatment

Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis.

Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener HC, Limmroth V.

Department of Neurology, University Hospital Essen, Essen, Germany. neuroweb@uni-essen.de

Azathioprine (Aza) is a widely used immunosuppressive drug in multiple sclerosis (MS) treatment. Recently, the incidence of secondary myelodysplastic syndromes (sMDS) associated with a poor prognosis was found to be elevated in patients treated with Aza for… read more »

Flu Vaccines, MS, and General Flu and Cold Information

Flu Vaccines, MS, and General Flu and Cold Information

Information for the Newly Diagnosed

Information for the Newly Diagnosed

Types of MS

Types of MS

Multiple sclerosis has been grouped into several main types. These include:

  • Relapsing-remitting MS — characterized by clearly defined attacks (relapses) followed by complete or partial recovery (remissions); most common form (75% at the time of diagnosis).

  • Primary-progressive MS — less common (10 to 15% at time of diagnosis), people with this type of MS have a nearly continuous worsening

Tysabri Press Release Source: HealthTalk Inc.

Press Release Source: HealthTalk Inc.